Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Steven L. Blumenthal
Introduction
Steven L. Blumenthal is a notable inventor based in Boynton Beach, Florida. He has made significant contributions to the field of cancer research through his innovative work on anticancer agents. His dedication to developing new therapeutic methods has the potential to change the landscape of cancer treatment.
Latest Patents
One of Steven L. Blumenthal's key patents is focused on high specificity anticancer agents. This patent describes a process for producing new anticancer drugs that can be administered in a nontoxic, proto-drug form. After a time delay that allows for differential concentration in target cancer or invasive tissues, the non-toxic drug is modified by an activation drug. This modification selectively provides toxic levels of a pharmacologically active agent to the target tissue. He holds 1 patent in this area.
Career Highlights
Steven L. Blumenthal is associated with the Walker Cancer Research Institute, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to finding effective and safe cancer treatments that can improve patient outcomes.
Collaborations
Throughout his career, Steven has collaborated with esteemed colleagues, including Evan Harris Walker and Eduardo Palomino. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer therapies.
Conclusion
Steven L. Blumenthal's contributions to cancer research through his innovative patent and collaborative efforts highlight his commitment to improving cancer treatment. His work exemplifies the potential of scientific innovation to make a meaningful impact on healthcare.